Tracey Walker, Contributing Editor
Aetna weight-loss program to include Belviq, Qsymia
Aetna is launching a pilot program to test the benefits of FDA-approved, prescription weight-loss drugs combined with lifestyle support.
Gestational diabetes screening should take place at 24 weeks
All pregnant women should be screened for gestational diabetes mellitus at 24 weeks gestation, even if they have no symptoms, according to new recommendations from the USPSTF.
Rise in hunger drives up hypoglycemia hospital admissions
Hunger in the United States may have important health consequences, including a higher risk of low blood sugar, a new study suggested.
FDA approves first combo therapy for advanced melanoma
GSK's Mekinist and Tafinlar combination received accelerated approval after priority review.
CAP deaths in ICU cut by early antibiotics, combined antibiotic therapy
In the last 10 years, deaths in the ICU from severe pneumococcal pneumonia have decreased notably. Earlier use of antibiotics and more combo therapy have made the difference.
Baxter voluntarily recalls select lots of premix parenteral nutrition
Baxter International has initiated a voluntary recall in the United States of 2 lots of premixed sterile intravenous (IV) parenteral nutrition products: CLINIMIX (Amino Acid in Dextrose) Injection and CLINIMIX E (Amino Acid with Electrolytes in Dextrose with Calcium) Injections to the user level because of complaints of particulate matter found in the products.
FDA approvals total 27 in 2013
FDA approved 27 new drugs last year, down from 39 new medications in 2012, which was a 15-year high, the Associated Press reported.
First once-daily dual bronchodilator for COPD approved
FDA approved umeclidinium and vilanterol inhalation powder (Anoro Ellipta, GlaxoSmithKline and Theravance) for the once-daily, long-term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.


View Results